Analysis of KLLN as a high-penetrance breast cancer predisposition gene

Breast Cancer Research and Treatment

Volumn 134, Issue 2, 2012, Pages 543-547

  Thompson, Ella R ^a   Gorringe, Kylie L ^a,b   Choong, David Y H ^a   Eccles, Diana M ^a,c   Mitchell, Gillian ^a   Campbell, Ian G ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

BRCAX; Familial breast cancer; Germline; KILLIN; Mutation

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GERM LINE; HIGH RISK PATIENT; HUMAN; KLLN GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR GENE; TUMOR SUPPRESSOR GENE;

ADULT; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LOSS OF HETEROZYGOSITY; MOLECULAR SEQUENCE DATA; PENETRANCE; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEINS;

EID: 84868193367     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2088-3     Document Type: Article

References (19)

1. Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12. doi:10.1186/bcr1377
2. Cho YJ, Liang P (2008) Killin is a p53-regulated nuclear inhibitor of DNA synthesis. Proc Natl Acad Sci USA 105(14):5396-5401. doi:10.1073/pnas. 0705410105
3. Bennett KL, Mester J, Eng C (2010) Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome. JAMA 304(24):2724-2731. doi:10.1001/jama.2010.1877
4. Eccles DM, Englefield P, Soulby MA, Campbell IG (1998) BRCA1 mutationsin southern England. Br J Cancer 77:2199-2203
5. Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD, Campbell IG (1996) Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res 56(4):719-721
6. Baxter SW, Choong DY, Eccles DM, Campbell IG (2001) Polymorphic variation in CYP19 and the risk of breast cancer. Carcinogenesis 22(2):347-349
7. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365-386
8. Gorringe KL, Choong DY, Williams LH, Ramakrishna M, Sridhar A, Qiu W, Bearfoot JL, Campbell IG (2008) Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer. Neoplasia 10(11):1253-1258
9. Jacobs S, Thompson ER, Nannya Y, Yamamoto G, Pillai R, Ogawa S, Bailey DK, Campbell IG (2007) Genome-wide, highresolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays. Cancer Res 67(6):2544-2551. doi:10.1158/0008- 5472. CAN-06-3597
10. Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68(4):820-823
11. Cavenee WK, Hansen MF, Nordenskjold M, Kock E, Maumenee I, Squire JA, Phillips RA, Gallie BL (1985) Genetic origin of mutations predisposing to retinoblastoma. Science 228(4698):501-503
12. Ng PC, Henikoff S (2001) Predicting deleterious amino acid substitutions. Genome Res 11(5):863-874. doi:10.1101/gr.176601
13. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248-249. doi:10.1038/nmeth0410-248
14. Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, Mooney SD, Radivojac P (2009) Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25(21):2744-2750. doi:10.1093/ bioinformatics/btp528
15. Ferrer-Costa C, Gelpi JL, Zamakola L, Parraga I, De La Cruz X, Orozco M (2005) PMUT: a web-based tool for the annotation of pathological mutations on proteins. Bioinformatics 21(14):3176-3178
16. Schwarz JM, Rodelsperger C, Schuelke M, Seelow D (2010) Mutation Taster evaluates disease-causing potential of sequence alterations. Nat Methods 7(8):575-576. doi:10.1038/nmeth0810-575
17. Bromberg Y, Rost B (2007) SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res 35(11):3823-3835. doi:10.1093/nar/gkm238
18. The 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467(7319):1061-1073. doi:10.1038/nature09534
19. Haga H, Yamada R, Ohnishi Y, Nakamura Y, Tanaka T (2002) Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190, 562 genetic variations in the human genome. Single-nucleotide polymorphism. J Hum Genet 47(11):605-610. doi:10.1007/s100380200092